Certara Recognized as a Top Biopharma Workplace for 2024
RADNOR, PA – 2024 年 6 月 12 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…
Certara2024 年 6 月 12 日
How QSP Brings Insights and Accelerates Bispecific Antibody Drug Development [China Webinar]
More than 50 bispecific antibodies are in oncology clinical development with a large diversity in…
Certara2024 年 6 月 7 日
Adaptive Trial Design for Phase 1 Dose-Finding Studies
Greater flexibility, efficiency and quicker dissemination of research findings to patient communities that stand to…
Certara2024 年 6 月 7 日
The State of Generative AI in Life Sciences
Discover how Generative AI in life sciences can transform drug discovery, clinical trials, and lab…
Certara2024 年 6 月 7 日
Technology Networks: Deregulating Psychedelics To Propel Clinical Research
Deregulating certain psychedelics could help to address unmet patient needs.
Certara2024 年 6 月 6 日
The future is now: Virtual clinical trials transforming drug development
Welcome to the forefront of drug development innovation! The drug development landscape is rapidly evolving,…
Certara2024 年 6 月 4 日
From Concept to Market: Value of MIFD & Simcyp Biopharmaceutics for Streamlined Drug Formulation and Approvals
Free Webinar for Biopharmaceutics and Drug Formulation Scientists Join us for an insightful discussion with…
Certara2024 年 6 月 4 日
Certara Expands the Simcyp™ Simulator Platform Advancing Biologics and Biopharmaceutics Capabilities
Updates advance the mission of the FDA’s new Quantitative Medicine Center of Excellence, which seeks…
Certara2024 年 6 月 3 日
